Anti-CD4 MoAb therapy in kidney transplantation - A pilot study in early prophylaxis of rejection

Transplantation

Volumn 62, Issue 10, 1996, Pages 1502-1506

  Dantal, Jacques ^b   Ninin, Emmanuelle ^a   Hourmant, Maryvonne ^a   Boeffard, Francoise ^a   Cantarovich, Diégo ^a   Giral, Magali ^a   Wijdenes, John ^b   Soulillou, Jean Paul ^a   Le Mauff, Brigitte ^a,c  

^a INSERM   (France)

^b Diaclone   (France)

^c NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; CORTICOSTEROID; CREATININE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY BF 5; OKT 4; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LIVER TOXICITY; MALE; PRIORITY JOURNAL; RASH;

EID: 0029851546     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611270-00020     Document Type: Article

References (26)

1. Wood KJ, Pearson TC, Darby C, Morris PJ. CD4: a potential target molecule for immunosuppressive therapy and tolerance induction. Transplant Rev 1991; 5: 150.
2. Sablinski T, Hancock WW, Tilney NL, Kupiec-Weglinski JZ. CD4 monoclonal antibodies in organ transplantation: a review of progress. Transplantation 1991; 52: 579.
3. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of tolerance in adult using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992; 54: 475.
4. Cosimi AB, Delmonico FL, Wright KJ, et al. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 1990; 108: 406.
5. Morel P, Vincent C, Cordier G, Panaye G, Carosella E, Revillard JP. Anti-CD4 monoclonal antibody administration in renal transplanted patients. Clin Immunol Immunopathol 1990; 56: 311.
6. Norman DJ, Bennett WM, Cobanoglu A, et al. Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience. Transplant Proc 1993; 25: 802.
7. Reinke P, Kern F, Fietze E, et al. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients: CD4+ T cells play an essential role in the rejection process. Transplant Proc 1995; 27: 859.
8. Piatier-Tonneau D, Scarmato P, Martin M, El Marhomy S, Auffray C. Characterization of 18 Workshop anti-CD4 mab: epitope mapping to CD4 mutants and effects on CD4-HLA class II interaction. In: Schlossman SF, Boumsell L, Gilks W, et al., eds. Leukocyte typing: V. White cell differenciation antigens, vol. 1. Oxford, Oxford University 1995: 476.
9. Hourmant M, Le Mauff B, Le Meur Y, et al. Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation: a pilot study. Transplantation 1994; 58: 377.
10. Hourmant M, Buzelin F, Dantal J, et al. Late acute failure of well HLA-matched renal allografts with capillary congestion and arteriolar thrombi. Transplantation 1995; 60: 1252.
11. Benjamin RJ, Qin S, Wise MP, Cobbold SP, Waldmann H. Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination. Eur J Immunol 1988; 18: 1079.
12. Henell KR, Cheever JM, Kimball JA, et al. OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics. Transplant Proc 1993; 25: 800.
13. Herve P, Racadot E, Wendung D, et al. Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience. Immunol Rev 1992; 129: 31.
14. Morel P, Revillard JP, Nicolas JF, Widjenes J, Rizova H, Thivolet J. Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoimmunity 1992; 5: 465.
15. Wendling D, Widjenes J, Racadot E, Morel-Fourrier B. Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis. J Rheumatol 1991; 18: 325.
16. Hiepe F, Volk HD, Apostoloff EA, Emmrich F. Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody. Lancet 1991; 338: 1529.
17. Horneff G, Burmester GR, Emmrich F, Kalden JR. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 1991; 34: 129.
18. Emmrich J, Seyfarth M, Fleig WE, Emmrich F. Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody. Lancet 1991; 338: 570.
19. Wee S-L, Colvin RB, Phelan JM, et al. Fc-receptor for mouse IgG1 (FcγRII) and antibody-mediated cell clearance in patients treated with Leu2a antibody. Transplantation 1989; 48: 1012.
20. van der Lubbe PA, Reiter C, Miltenburg AM, et al. Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action. Scand J Immunol 1994; 39: 286.
21. Scoazec JY, Feldmann G. In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications. Hepatology 1991; 14: 789.
22. Emmrich F, Horneff G, Guse A, Kinne R, Burnest G, Becker W. Unspecific accumulation of anti-CD4 antibodies and negative signaling but not modulation of the CD4-molecule may contribute to the efficacy of anti-CD4 treatment in rheumatoid arthritis. B J Rheumatol 1991; 30 (suppl 2): 100.
23. Vincent C, Fournel S, Widjenes J, Revillard JP. Specific hyporesponsiveness of alloreactive peripheral T cells induced by CD4 antibodies. Eur J Immunol 1995; 25: 816.
24. Meiser BM, Reiter C, Reichenspurner H, et al. Chimeric monoclonal CD4 antibody - a novel immunosuppressant for clinical heart transplantation. Transplantation 1994; 58: 419.
25. Field EH, Rouse TM, Fleming AL, Jamali I, Cowdery JS. Altered IFN-γ and IL-4 pattern lymphokine secretion in mice partially depleted of CD4 T cells by anti-CD4 monoclonal antibody. J Immunol 1992; 149: 1131.
26. Murray JS, Madri J, Tite J, Carding SR, Bottomly K. MHC control of CD4+ T cell subset activation. J Exp Med 1989; 170: 2135.